Focal neuroendocrine differentiation of conventional prostate adenocarcinoma as a prognostic factor after radical prostatectomy: A systematic review and meta-analysis

Mehdi Kardoust Parizi, Takehiro Iwata, Shoji Kimura, Florian Janisch, Mohammad Abufaraj, Pierre I. Karakiewicz, Dmitry Enikeev, Leonid M. Rapoport, Georg Hutterer, Shahrokh F. Shariat

Research output: Contribution to journalReview article

Abstract

The biologic and prognostic value of focal neuroendocrine differentiation (NED) in conventional prostate adenocarcinoma (PC) patients who undergo radical prostatectomy (RP) remains controversial. In this systematic review and meta-analysis, we assessed the association of focal NED in conventional PC with oncological outcomes after RP. A literature search using PubMed, Scopus, Web of Science, and Cochrane Library was conducted on December 2018 to find relevant studies according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. We used a fixed-effect model to analyze the impact of focal NED in RP specimen on progression-free survival defined by biochemical recurrence (BCR). A total of 16 studies with the outcomes of disease progression and survival were eligible. No patient in these studies received androgen deprivation therapy prior to RP. Eleven studies found no significant correlation between focal NED and outcomes of interest, while five studies reported a significant association of focal NED assessed by immunohistochemical chromogranin A or serotonin staining with BCR or survival. Focal NED was associated with higher BCR rates after RP with a pooled HR of 1.39 (95% CI 1.07-1.81) in five studies. No heterogeneity was reported in this analysis (I2 = 21.7%, p = 0.276). In conclusion, focal NED in conventional PC is associated with worse prognosis after RP. Its presence should be reported in pathologic reports and its true clinical impact should be assessed in well-designed prospective controlled studies.

Original languageEnglish
Article number1374
JournalInternational journal of molecular sciences
Volume20
Issue number6
DOIs
Publication statusPublished - Mar 2 2019

Fingerprint

Prostatectomy
Meta-Analysis
Prostate
Adenocarcinoma
Chromogranin A
Androgens
Serotonin
Recurrence
progressions
Library Science
serotonin
deprivation
Survival
prognosis
PubMed
staining
Disease-Free Survival
Disease Progression
Outcome Assessment (Health Care)
therapy

Keywords

  • Chromogranin A
  • Neuroendocrine differentiation
  • Oncological outcome
  • Prostate cancer
  • Radical prostatectomy
  • Survival

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Focal neuroendocrine differentiation of conventional prostate adenocarcinoma as a prognostic factor after radical prostatectomy : A systematic review and meta-analysis. / Parizi, Mehdi Kardoust; Iwata, Takehiro; Kimura, Shoji; Janisch, Florian; Abufaraj, Mohammad; Karakiewicz, Pierre I.; Enikeev, Dmitry; Rapoport, Leonid M.; Hutterer, Georg; Shariat, Shahrokh F.

In: International journal of molecular sciences, Vol. 20, No. 6, 1374, 02.03.2019.

Research output: Contribution to journalReview article

Parizi, Mehdi Kardoust ; Iwata, Takehiro ; Kimura, Shoji ; Janisch, Florian ; Abufaraj, Mohammad ; Karakiewicz, Pierre I. ; Enikeev, Dmitry ; Rapoport, Leonid M. ; Hutterer, Georg ; Shariat, Shahrokh F. / Focal neuroendocrine differentiation of conventional prostate adenocarcinoma as a prognostic factor after radical prostatectomy : A systematic review and meta-analysis. In: International journal of molecular sciences. 2019 ; Vol. 20, No. 6.
@article{773ea2cfcbcb4c61998c14d2b8050c60,
title = "Focal neuroendocrine differentiation of conventional prostate adenocarcinoma as a prognostic factor after radical prostatectomy: A systematic review and meta-analysis",
abstract = "The biologic and prognostic value of focal neuroendocrine differentiation (NED) in conventional prostate adenocarcinoma (PC) patients who undergo radical prostatectomy (RP) remains controversial. In this systematic review and meta-analysis, we assessed the association of focal NED in conventional PC with oncological outcomes after RP. A literature search using PubMed, Scopus, Web of Science, and Cochrane Library was conducted on December 2018 to find relevant studies according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. We used a fixed-effect model to analyze the impact of focal NED in RP specimen on progression-free survival defined by biochemical recurrence (BCR). A total of 16 studies with the outcomes of disease progression and survival were eligible. No patient in these studies received androgen deprivation therapy prior to RP. Eleven studies found no significant correlation between focal NED and outcomes of interest, while five studies reported a significant association of focal NED assessed by immunohistochemical chromogranin A or serotonin staining with BCR or survival. Focal NED was associated with higher BCR rates after RP with a pooled HR of 1.39 (95{\%} CI 1.07-1.81) in five studies. No heterogeneity was reported in this analysis (I2 = 21.7{\%}, p = 0.276). In conclusion, focal NED in conventional PC is associated with worse prognosis after RP. Its presence should be reported in pathologic reports and its true clinical impact should be assessed in well-designed prospective controlled studies.",
keywords = "Chromogranin A, Neuroendocrine differentiation, Oncological outcome, Prostate cancer, Radical prostatectomy, Survival",
author = "Parizi, {Mehdi Kardoust} and Takehiro Iwata and Shoji Kimura and Florian Janisch and Mohammad Abufaraj and Karakiewicz, {Pierre I.} and Dmitry Enikeev and Rapoport, {Leonid M.} and Georg Hutterer and Shariat, {Shahrokh F.}",
year = "2019",
month = "3",
day = "2",
doi = "10.3390/ijms20061374",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "6",

}

TY - JOUR

T1 - Focal neuroendocrine differentiation of conventional prostate adenocarcinoma as a prognostic factor after radical prostatectomy

T2 - A systematic review and meta-analysis

AU - Parizi, Mehdi Kardoust

AU - Iwata, Takehiro

AU - Kimura, Shoji

AU - Janisch, Florian

AU - Abufaraj, Mohammad

AU - Karakiewicz, Pierre I.

AU - Enikeev, Dmitry

AU - Rapoport, Leonid M.

AU - Hutterer, Georg

AU - Shariat, Shahrokh F.

PY - 2019/3/2

Y1 - 2019/3/2

N2 - The biologic and prognostic value of focal neuroendocrine differentiation (NED) in conventional prostate adenocarcinoma (PC) patients who undergo radical prostatectomy (RP) remains controversial. In this systematic review and meta-analysis, we assessed the association of focal NED in conventional PC with oncological outcomes after RP. A literature search using PubMed, Scopus, Web of Science, and Cochrane Library was conducted on December 2018 to find relevant studies according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. We used a fixed-effect model to analyze the impact of focal NED in RP specimen on progression-free survival defined by biochemical recurrence (BCR). A total of 16 studies with the outcomes of disease progression and survival were eligible. No patient in these studies received androgen deprivation therapy prior to RP. Eleven studies found no significant correlation between focal NED and outcomes of interest, while five studies reported a significant association of focal NED assessed by immunohistochemical chromogranin A or serotonin staining with BCR or survival. Focal NED was associated with higher BCR rates after RP with a pooled HR of 1.39 (95% CI 1.07-1.81) in five studies. No heterogeneity was reported in this analysis (I2 = 21.7%, p = 0.276). In conclusion, focal NED in conventional PC is associated with worse prognosis after RP. Its presence should be reported in pathologic reports and its true clinical impact should be assessed in well-designed prospective controlled studies.

AB - The biologic and prognostic value of focal neuroendocrine differentiation (NED) in conventional prostate adenocarcinoma (PC) patients who undergo radical prostatectomy (RP) remains controversial. In this systematic review and meta-analysis, we assessed the association of focal NED in conventional PC with oncological outcomes after RP. A literature search using PubMed, Scopus, Web of Science, and Cochrane Library was conducted on December 2018 to find relevant studies according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines. We used a fixed-effect model to analyze the impact of focal NED in RP specimen on progression-free survival defined by biochemical recurrence (BCR). A total of 16 studies with the outcomes of disease progression and survival were eligible. No patient in these studies received androgen deprivation therapy prior to RP. Eleven studies found no significant correlation between focal NED and outcomes of interest, while five studies reported a significant association of focal NED assessed by immunohistochemical chromogranin A or serotonin staining with BCR or survival. Focal NED was associated with higher BCR rates after RP with a pooled HR of 1.39 (95% CI 1.07-1.81) in five studies. No heterogeneity was reported in this analysis (I2 = 21.7%, p = 0.276). In conclusion, focal NED in conventional PC is associated with worse prognosis after RP. Its presence should be reported in pathologic reports and its true clinical impact should be assessed in well-designed prospective controlled studies.

KW - Chromogranin A

KW - Neuroendocrine differentiation

KW - Oncological outcome

KW - Prostate cancer

KW - Radical prostatectomy

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=85063628702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063628702&partnerID=8YFLogxK

U2 - 10.3390/ijms20061374

DO - 10.3390/ijms20061374

M3 - Review article

C2 - 30893781

AN - SCOPUS:85063628702

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 6

M1 - 1374

ER -